Three stocks positioned for growth in the biotech sector: analyst
Investors looking at the biotech sector should look for drug companies that run well-designed critical clinical trials and have a good outreach, one analyst says. David Nierengarten, senior analyst at Wedbush, told BNN Bloomberg on Friday that selecting a...